University of Kent bioscientists receive grant to research novel cancer treatmentMarch 16, 2004Dr Phil Blower and Dr Dan Lloyd from the Department of Biosciences at the University of Kent - together with Dr Paul Marsden at the St Thomas' Hospital Clinical PET Centre in London - have been awarded £347,906 from the Engineering and Physical Sciences Research Council and the Medical Research Council for a project entitled Radiocopper complexes for imaging and treatment of hypoxic tissues. Dan Lloyd explains that 'Hypoxia is a shortage of oxygen in tissues and occurs in many diseases such as stroke, heart disease and cancer. It is one of the main causes of cancer treatment failure, since hypoxic tumours are often resistant to conventional radiotherapy and chemotherapy. This multi-disciplinary project will involve the synthesis and evaluation of molecules, coupled to radioactive isotopes that specifically target hypoxic tissue. It is hoped that the work will result in the development of both imaging procedures to locate hypoxic tissues within the body, and therapeutic strategies for the treatment of resistant hypoxic tumours.' Phil Blower adds, 'The imaging procedures will use PET (positron emission tomography), a radioisotope imaging technique especially useful in imaging cancer and brain function. The UK lags behind many other countries in establishing PET centres and has only a small number of them. The PET centre at St Thomas' Hospital was set up more than a decade ago and was the UK's first PET centre offering a routine service to patients, but more centres are now needed to bring these new technologies to cancer patients across the country.' Dr Dan Lloyd and Dr Phil Blower are members of the Cancer Research Group at the University of Kent that was established to reflect the growing amount of research activities within the Department of Biosciences seeking new approaches to the diagnosis and treatment of cancer. | |||||||||||||||||||||
|
Related Cancer News Articles Bisphenol A linked to metabolic syndrome in human tissue New research from the University of Cincinnati (UC) implicates the primary chemical used to produce hard plastics-bisphenol A (BPA)-as a risk factor for metabolic syndrome and its consequences. African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD). Atomic structure of the mammalian 'fatty acid factory' determined Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders. International team reveals first prognosticator of survival in aggressive cancer The tumor suppressor gene pRb2/p130 may provide the first independent prognostic biomarker in cases of soft tissue sarcoma (STS). M. D. Anderson study finds change in HER2 status after treatment with Herceptin Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery. M. D. Anderson study finds racial disparities in radiation therapy rates for breast cancer Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center. NC State Is First University in Nation to Offer Canine Bone Marrow Transplants Dogs suffering from lymphoma will be able to receive the same type of medical treatment as their human counterparts, as North Carolina State University becomes the first university in the nation to offer canine bone marrow transplants in a clinical setting. DNA editing tool flips its target Imagine having to copy an entire book by hand without missing a comma. Our cells face a similar task every time they divide. They must duplicate both their DNA and a subtle pattern of punctuation-like modifications on the DNA known as methylation. What a Sleep Study Can Reveal About Fibromyalgia Research engineers and sleep medicine specialists from two Michigan universities have joined technical and clinical hands to put innovative quantitative analysis, signal-processing technology and computer algorithms to work in the sleep lab. Stem cell research puts interstate rivalry on hold Victoria and New South Wales have put aside their competitive interstate rivalry to collaborate on a stem cell research project, as announced by Innovation Minister Gavin Jennings and NSW Minister for Science and Medical Research, Verity Firth, today. More Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||